SCHEMBL3314932

SCHEMBL3314932

COc1cc(NC(=O)NCCc2ccc(Cl)c(Cl)c2)ccc1-n1cnc(C)c1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 12/20 0.61
PSEN2 P49810 12/20 0.61
APH1B Q8WW43 12/20 0.61
NCSTN Q92542 12/20 0.61
APH1A Q96BI3 12/20 0.61
PSENEN Q9NZ42 12/20 0.61
QPCT Q16769 2/20 0.52
CNR1 P21554 2/20 0.50
POLB P06746 1/20 0.50
RAF1 P04049 1/20 0.47
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GPR142 Q7Z601 1/20 0.43
FPR2 P25090 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3312331 0.91 PSEN1 (0.58) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9266733 0.85 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9264269 0.85 QPCT (0.58) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13398046 0.82 QPCT (0.58) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8819690 0.80 PSEN1 (0.63) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8819338 0.78 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13398054 0.78 PSEN1 (0.74) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL759811 0.78 PSEN1 (0.71) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14036697 0.78 PSEN1 (0.57) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8819599 0.78 PSEN1 (0.71) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100105904-A1 UREA TYPE CINNAMIDE DERIVATIVE EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-04-29 US disclosed
US-20100105904-A1 UREA TYPE CINNAMIDE DERIVATIVE EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-04-29 US disclosed
US-20100105904-A1 UREA TYPE CINNAMIDE DERIVATIVE EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-04-29 US disclosed
EP-2019093-A1 UREA TYPE CINNAMIDE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2009-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105904-A1 UREA TYPE CINNAMIDE DERIVATIVE SLC14A1, UTS2R, MAN2B1 PSEN1 3476/4885PSEN2 4115/4885APH1B 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.